Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.
about
Biological Stereoselectivity of Atropisomeric Natural Products and DrugsBombesin receptor subtype 3 as a potential target for obesity and diabetes.Substituted oxadiazoles: a patent review (2010 - 2012).Bombesin receptor subtype-3-expressing neurons regulate energy homeostasis through a novel neuronal pathway in the hypothalamus.
P2860
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Discovery of MK-7725, A Potent ...... for the Treatment of Obesity.
@ast
Discovery of MK-7725, A Potent ...... for the Treatment of Obesity.
@en
type
label
Discovery of MK-7725, A Potent ...... for the Treatment of Obesity.
@ast
Discovery of MK-7725, A Potent ...... for the Treatment of Obesity.
@en
prefLabel
Discovery of MK-7725, A Potent ...... for the Treatment of Obesity.
@ast
Discovery of MK-7725, A Potent ...... for the Treatment of Obesity.
@en
P2093
P2860
P356
P1476
Discovery of MK-7725, A Potent ...... for the Treatment of Obesity.
@en
P2093
Alison M Strack
Donald J Marsh
Harry R Chobanian
Jasminka Dragovic
Jianmei Pang
Joseph M Metzger
Judith N Gorski
Kate Raustad
Kathy Lyons
Linus S Lin
P2860
P304
P356
10.1021/ML200304J
P577
2012-01-21T00:00:00Z